KR927003530A - Use of local anesthetics in the manufacture of pharmaceutical formulations for iontophoresis - Google Patents

Use of local anesthetics in the manufacture of pharmaceutical formulations for iontophoresis Download PDF

Info

Publication number
KR927003530A
KR927003530A KR1019920701761A KR920701761A KR927003530A KR 927003530 A KR927003530 A KR 927003530A KR 1019920701761 A KR1019920701761 A KR 1019920701761A KR 920701761 A KR920701761 A KR 920701761A KR 927003530 A KR927003530 A KR 927003530A
Authority
KR
South Korea
Prior art keywords
iontophoresis
manufacture
pharmaceutical formulations
local anesthetics
lopivacaine
Prior art date
Application number
KR1019920701761A
Other languages
Korean (ko)
Inventor
프레드릭 브로베르그
한스 에버스
Original Assignee
클래스 빌헬름슨
악티에볼라게트 아스트라
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 클래스 빌헬름슨, 악티에볼라게트 아스트라 filed Critical 클래스 빌헬름슨
Publication of KR927003530A publication Critical patent/KR927003530A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음No content

Description

이온삼투요법용 제약 제제의 제조에 있어서의 국소 마취제의 용도Use of local anesthetics in the manufacture of pharmaceutical formulations for iontophoresis

[도면의 간단한 설명][Brief Description of Drawings]

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (4)

이온삼투요법용 제약 제제의 제조에 사용하기 위한 로피바카인의 제약학적 허용되는 염의 용도.Use of a pharmaceutically acceptable salt of lopivacaine for use in the manufacture of a pharmaceutical formulation for iontophoresis. 제1항에 있어서, 로피바카인이 그의 염산염 형태인 것을 특징으로 하는 용도.Use according to claim 1, characterized in that lopivacaine is in the hydrochloride form thereof. 로피바카인의 제약학적 허용되는 염을 이온삼투요법적 유효량으로 사용하는 것을 특징으로 하는 이온삼투요법에 의한 치료 방법.A method of treatment by iontophoresis, characterized in that a pharmaceutically acceptable salt of lopivacaine is used in an ionically effective amount. 활성 성분이 로피바카인의 제약학적 허용되는 염인 것을 특징으로 하는 이온 삼투요법에 사용하기 위한 제약 제제.Pharmaceutical formulation for use in iontophoresis, wherein the active ingredient is a pharmaceutically acceptable salt of lopivacaine. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019920701761A 1990-01-26 1991-01-24 Use of local anesthetics in the manufacture of pharmaceutical formulations for iontophoresis KR927003530A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9000288A SE9000288D0 (en) 1990-01-26 1990-01-26 NEW USE
SE9000288-2 1990-01-26
PCT/SE1991/000053 WO1991011182A1 (en) 1990-01-26 1991-01-24 Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis

Publications (1)

Publication Number Publication Date
KR927003530A true KR927003530A (en) 1992-12-18

Family

ID=20378368

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920701761A KR927003530A (en) 1990-01-26 1991-01-24 Use of local anesthetics in the manufacture of pharmaceutical formulations for iontophoresis

Country Status (8)

Country Link
EP (1) EP0597833A1 (en)
JP (1) JPH05503704A (en)
KR (1) KR927003530A (en)
AU (1) AU650002B2 (en)
CA (1) CA2073028A1 (en)
HU (1) HU210322B (en)
SE (1) SE9000288D0 (en)
WO (1) WO1991011182A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6295469B1 (en) 1997-11-14 2001-09-25 Alza Corporation Formulation for electrically assisted delivery of lidocaine and epinephrine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379266D1 (en) * 1983-08-01 1989-04-06 Astra Laekemedel Ab L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same

Also Published As

Publication number Publication date
HU9202444D0 (en) 1992-10-28
EP0597833A1 (en) 1994-05-25
WO1991011182A1 (en) 1991-08-08
AU650002B2 (en) 1994-06-09
HU210322B (en) 1995-03-28
HUT65098A (en) 1994-04-28
CA2073028A1 (en) 1991-07-27
AU7231291A (en) 1991-08-21
JPH05503704A (en) 1993-06-17
SE9000288D0 (en) 1990-01-26

Similar Documents

Publication Publication Date Title
CA2025078A1 (en) External Analgesic lotion and Method of Making
FR2673538B1 (en) COMPOSITION BASED ON 3- [2- (DIMETHYLAMINO) ETHYL] -N-METHYL-1H-INDOLE-5 METHANESULFONAMIDE FOR ORAL ADMINISTRATION.
KR900700089A (en) Pharmaceutical Compositions for Systemic Skin Permeable Administration
KR920002144A (en) Inflammatory bowel disease prevention and treatment containing zinc L-carnosine salt or its complex as an active ingredient
DE69715049D1 (en) EXTERNAL CONTAINING TRANILAST AND METHOD FOR THE PRODUCTION THEREOF
KR910000703A (en) Antagonists of Tetrazol Stimulating Amino Acid Receptors
RU93032613A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION
ATE15596T1 (en) PHARMACEUTICAL AGENT.
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
KR940018087A (en) 6-chloro-5-fluoro-3- (2-tenoyl) -2-oxindol-I-carboxamide as analgesic and anti-inflammatory agent
SE8804628D0 (en) NEW COMPOUNDS
KR950016760A (en) Hemorrhoids Treatment
ATE114244T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLUTICASONE PROPIONATE AND OXIKONAZOLE OR ITS SALT FOR LOCAL APPLICATION.
DE69736554D1 (en) OPHTHALMIC MEDICINAL COMPOSITION
LV10267A (en) A compound for the purpose of obtaining a compound compound
KR900005974A (en) Sexual Dysfunction in Men
TR199801184T2 (en) New compounds with analgesic action.
KR930019224A (en) Abortion Hazard Remedy
KR927003530A (en) Use of local anesthetics in the manufacture of pharmaceutical formulations for iontophoresis
DE10299023I1 (en) Active substance with an antineoplastic effect and which enhances the antineoplastic effect
KR920703060A (en) Pharmaceutical Formulations
KR960003718A (en) Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases
KR960003717A (en) Use of elliprodil and its enantiomers for the manufacture of a medicament useful for the prevention of peripheral neuropathy caused by anticancer agents
KR920019349A (en) Use of R (+)-3-amino-1-hydroxy-pyrrolidin-2-one to treat anxiety
KR900017599A (en) Pharmaceutical composition for tumor treatment

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination